Literature DB >> 30297325

Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis.

Laura Martinez-Prat1, David Lucia1, Claudia Ibarra2, Michael Mahler3, Thierry Dervieux4.   

Abstract

Entities:  

Keywords:  anti-CCP; autoantibodies; early rheumatoid arthritis; rheumatoid arthritis; rheumatoid factor

Mesh:

Substances:

Year:  2018        PMID: 30297325     DOI: 10.1136/annrheumdis-2018-213818

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis.

Authors:  Maria Isabel Trejo-Zambrano; Eduardo Gómez-Bañuelos; Felipe Andrade
Journal:  Antioxid Redox Signal       Date:  2021-06-04       Impact factor: 7.468

Review 2.  Neutrophil Extracellular Traps Tied to Rheumatoid Arthritis: Points to Ponder.

Authors:  Wenpeng Song; Jing Ye; Nanfang Pan; Chunyu Tan; Martin Herrmann
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

Review 3.  Inhibition of NETosis for treatment purposes: friend or foe?

Authors:  Tahmineh Mohammadi Chamardani; Samaneh Amiritavassoli
Journal:  Mol Cell Biochem       Date:  2022-01-07       Impact factor: 3.842

Review 4.  The Citrullination-Neutrophil Extracellular Trap Axis in Chronic Diseases.

Authors:  Martin Maronek; Roman Gardlik
Journal:  J Innate Immun       Date:  2022-03-09       Impact factor: 7.111

5.  Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.

Authors:  M Kristen Demoruelle; Hong Wang; Ryan L Davis; Ashley Visser; Johnny Hoang; Jill M Norris; V Michael Holers; Kevin D Deane; Erika Darrah
Journal:  Arthritis Res Ther       Date:  2021-06-06       Impact factor: 5.156

6.  The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients.

Authors:  Bogdan Kolarz; Marek Ciesla; Ann K Rosenthal; Magdalena Dryglewska; Maria Majdan
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-02-11       Impact factor: 5.346

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.